Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Other Non-Current Liabilities of $61.9 million for Q1 2026, down 2.28% year-over-year from $63.3 million in Q1 2025, and up 1.94% quarter-over-quarter from $60.7 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Other Non-Current Liabilities data on file, last reported at $61.9 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $61.9 million, down 2.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.9 million (down 2.28% YoY), and the FY2025 annual result was $60.7 million, up 190.61% from the prior year.
- Other Non-Current Liabilities climbed to $61.9 million in Q1 2026 per STVN's latest filing, from $60.7 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $64.5 million in Q3 2025 and troughed at -$67.0 million in Q4 2024.
- A 5-year average of $28.2 million and a median of $55.3 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities slumped 796.8% in 2022, then soared 1798.68% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at -$18.5 million in 2022, then plunged by 182.58% to -$52.2 million in 2023, then fell by 28.4% to -$67.0 million in 2024, then soared by 190.61% to $60.7 million in 2025, then advanced by 1.94% to $61.9 million in 2026.
- Business Quant data shows STVN's Other Non-Current Liabilities at $61.9 million in Q1 2026, $60.7 million in Q4 2025, and $64.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.89 Mn |
| Dec 31, 2025 | 60.71 Mn |
| Sep 30, 2025 | 64.48 Mn |
| Jun 30, 2025 | 62.93 Mn |
| Mar 31, 2025 | 63.33 Mn |
| Dec 31, 2024 | -67.00 Mn |
| Sep 30, 2024 | 57.29 Mn |
| Jun 30, 2024 | 55.29 Mn |
| Mar 31, 2024 | 55.28 Mn |
| Dec 31, 2023 | -52.18 Mn |
| Sep 30, 2023 | 56.68 Mn |
| Jun 30, 2023 | 36.97 Mn |
| Mar 31, 2023 | 22.25 Mn |
| Dec 31, 2022 | -18.47 Mn |
| Sep 30, 2022 | 16.13 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | -2.12 Mn |
| Jun 30, 2021 | 2.21 Mn |